• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于熵的替代终点验证的非参数检验。

An entropy-based nonparametric test for the validation of surrogate endpoints.

机构信息

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

出版信息

Stat Med. 2012 Jun 30;31(14):1517-30. doi: 10.1002/sim.4500. Epub 2012 Feb 17.

DOI:10.1002/sim.4500
PMID:22344829
Abstract

We present a nonparametric test to validate surrogate endpoints based on measure of divergence and random permutation. This test is a proposal to directly verify the Prentice statistical definition of surrogacy. The test does not impose distributional assumptions on the endpoints, and it is robust to model misspecification. Our simulation study shows that the proposed nonparametric test outperforms the practical test of the Prentice criterion in terms of both robustness of size and power. We also evaluate the performance of three leading methods that attempt to quantify the effect of surrogate endpoints. The proposed method is applied to validate magnetic resonance imaging lesions as the surrogate endpoint for clinical relapses in a multiple sclerosis trial.

摘要

我们提出了一种基于分歧度量和随机排列的非参数检验方法,用于验证替代终点。该检验方法是对 Prentice 替代终点统计学定义的直接验证,不对终点进行分布假设,并且对模型误设具有稳健性。我们的模拟研究表明,该非参数检验在大小和功效的稳健性方面均优于 Prentice 准则的实用检验。我们还评估了三种尝试量化替代终点效果的领先方法的性能。该方法应用于验证多发性硬化症试验中磁共振成像病变作为临床复发的替代终点。

相似文献

1
An entropy-based nonparametric test for the validation of surrogate endpoints.基于熵的替代终点验证的非参数检验。
Stat Med. 2012 Jun 30;31(14):1517-30. doi: 10.1002/sim.4500. Epub 2012 Feb 17.
2
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.联合 MRI 病变和复发作为多发性硬化症残疾的替代指标。
Neurology. 2011 Nov 1;77(18):1684-90. doi: 10.1212/WNL.0b013e31823648b9. Epub 2011 Oct 5.
3
Alternative methods to evaluate trial level surrogacy.评估试验水平替代指标的替代方法。
Clin Trials. 2008;5(3):194-208. doi: 10.1177/1740774508091677.
4
Validation of surrogate markers in multiple randomized clinical trials with repeated measurements: canonical correlation approach.在多次重复测量的随机临床试验中对替代标志物进行验证:典型相关分析方法
Biometrics. 2004 Dec;60(4):845-53. doi: 10.1111/j.0006-341X.2004.00239.x.
5
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.一项干扰素β-1b 治疗原发性进展型和复发缓解型-进展型多发性硬化症的单中心、随机、双盲、安慰剂对照研究。
Mult Scler. 2009 Oct;15(10):1195-205. doi: 10.1177/1352458509106937. Epub 2009 Sep 29.
6
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.磁共振活跃病灶作为多发性硬化症个体水平复发的替代指标。
Mult Scler. 2011 May;17(5):541-9. doi: 10.1177/1352458510391837. Epub 2010 Dec 9.
7
The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints.生物标志物替代评估方案:对生物标志物替代相关文献的综述以及关于用于评估生物标志物作为替代终点状态的基于标准、定量、多维度层次证据方案的提议。
Stat Methods Med Res. 2008 Jun;17(3):303-40. doi: 10.1177/0962280207082719. Epub 2007 Oct 9.
8
A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients.多发性硬化症患者磁共振成像病灶计数数据的纵向模型。
Stat Med. 2012 Feb 28;31(5):449-69. doi: 10.1002/sim.4394. Epub 2011 Oct 3.
9
Does the Prentice criterion validate surrogate endpoints?普伦蒂斯标准是否验证了替代终点?
Stat Med. 2004 May 30;23(10):1571-8. doi: 10.1002/sim.1780.
10
Seeing injectable MS therapies differently: they are more similar than different.对注射用多发性硬化症疗法有不同看法:它们的相似之处多于不同之处。
Neurology. 2009 Jun 9;72(23):1972-3. doi: 10.1212/WNL.0b013e3181a92c82. Epub 2009 May 13.

引用本文的文献

1
Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.知情决策:代理评估的统计方法及其在许可和报销评估中的作用。
Pharm Stat. 2022 Jul;21(4):740-756. doi: 10.1002/pst.2219.